Cargando…

Unresolved Complexity in the Gene Regulatory Network Underlying EMT

Epithelial to mesenchymal transition (EMT) is the process whereby a polarized epithelial cell ceases to maintain cell-cell contacts, loses expression of characteristic epithelial cell markers, and acquires mesenchymal cell markers and properties such as motility, contractile ability, and invasivenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavin, Deborah P., Tiwari, Vijay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235173/
https://www.ncbi.nlm.nih.gov/pubmed/32477926
http://dx.doi.org/10.3389/fonc.2020.00554
_version_ 1783535908205625344
author Lavin, Deborah P.
Tiwari, Vijay K.
author_facet Lavin, Deborah P.
Tiwari, Vijay K.
author_sort Lavin, Deborah P.
collection PubMed
description Epithelial to mesenchymal transition (EMT) is the process whereby a polarized epithelial cell ceases to maintain cell-cell contacts, loses expression of characteristic epithelial cell markers, and acquires mesenchymal cell markers and properties such as motility, contractile ability, and invasiveness. A complex process that occurs during development and many disease states, EMT involves a plethora of transcription factors (TFs) and signaling pathways. Whilst great advances have been made in both our understanding of the progressive cell-fate changes during EMT and the gene regulatory networks that drive this process, there are still gaps in our knowledge. Epigenetic modifications are dynamic, chromatin modifying enzymes are vast and varied, transcription factors are pleiotropic, and signaling pathways are multifaceted and rarely act alone. Therefore, it is of great importance that we decipher and understand each intricate step of the process and how these players at different levels crosstalk with each other to successfully orchestrate EMT. A delicate balance and fine-tuned cooperation of gene regulatory mechanisms is required for EMT to occur successfully, and until we resolve the unknowns in this network, we cannot hope to develop effective therapies against diseases that involve aberrant EMT such as cancer. In this review, we focus on data that challenge these unknown entities underlying EMT, starting with EMT stimuli followed by intracellular signaling through to epigenetic mechanisms and chromatin remodeling.
format Online
Article
Text
id pubmed-7235173
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72351732020-05-29 Unresolved Complexity in the Gene Regulatory Network Underlying EMT Lavin, Deborah P. Tiwari, Vijay K. Front Oncol Oncology Epithelial to mesenchymal transition (EMT) is the process whereby a polarized epithelial cell ceases to maintain cell-cell contacts, loses expression of characteristic epithelial cell markers, and acquires mesenchymal cell markers and properties such as motility, contractile ability, and invasiveness. A complex process that occurs during development and many disease states, EMT involves a plethora of transcription factors (TFs) and signaling pathways. Whilst great advances have been made in both our understanding of the progressive cell-fate changes during EMT and the gene regulatory networks that drive this process, there are still gaps in our knowledge. Epigenetic modifications are dynamic, chromatin modifying enzymes are vast and varied, transcription factors are pleiotropic, and signaling pathways are multifaceted and rarely act alone. Therefore, it is of great importance that we decipher and understand each intricate step of the process and how these players at different levels crosstalk with each other to successfully orchestrate EMT. A delicate balance and fine-tuned cooperation of gene regulatory mechanisms is required for EMT to occur successfully, and until we resolve the unknowns in this network, we cannot hope to develop effective therapies against diseases that involve aberrant EMT such as cancer. In this review, we focus on data that challenge these unknown entities underlying EMT, starting with EMT stimuli followed by intracellular signaling through to epigenetic mechanisms and chromatin remodeling. Frontiers Media S.A. 2020-05-12 /pmc/articles/PMC7235173/ /pubmed/32477926 http://dx.doi.org/10.3389/fonc.2020.00554 Text en Copyright © 2020 Lavin and Tiwari. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Lavin, Deborah P.
Tiwari, Vijay K.
Unresolved Complexity in the Gene Regulatory Network Underlying EMT
title Unresolved Complexity in the Gene Regulatory Network Underlying EMT
title_full Unresolved Complexity in the Gene Regulatory Network Underlying EMT
title_fullStr Unresolved Complexity in the Gene Regulatory Network Underlying EMT
title_full_unstemmed Unresolved Complexity in the Gene Regulatory Network Underlying EMT
title_short Unresolved Complexity in the Gene Regulatory Network Underlying EMT
title_sort unresolved complexity in the gene regulatory network underlying emt
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235173/
https://www.ncbi.nlm.nih.gov/pubmed/32477926
http://dx.doi.org/10.3389/fonc.2020.00554
work_keys_str_mv AT lavindeborahp unresolvedcomplexityinthegeneregulatorynetworkunderlyingemt
AT tiwarivijayk unresolvedcomplexityinthegeneregulatorynetworkunderlyingemt